Shu Len Liu

Title: Innovations by Shu Len Liu in Fibrinogen Complexes

Introduction

Shu Len Liu is a notable inventor based in Cerritos, California, recognized for his contributions to the field of medical compositions. He holds two patents that focus on the preparation and application of fibrinogen complexes derived from human plasma. His work has significant implications for medical treatments, particularly in wound healing and surgical applications.

Latest Patents

Liu's latest patents include a method of preparing a topical fibrinogen complex. This method involves separating a cryoprecipitate from human plasma, suspending it in a salt-containing buffer, and treating the supernatant through affinity-chromatography. This process allows for the selective adsorption of plasminogen, resulting in a fraction with less than 10 µg/ml plasminogen, which minimizes the need for additional fibrinolysis inhibitors. The fibrinogen-containing composition produced is advantageous due to its low plasminogen content, enhancing its safety and efficacy. Additionally, the topical fibrinogen complex reacts with thrombin to function as a fibrin sealant, characterized by the absence of detectable levels of lipid-enveloped virus activity and other non-human proteins.

Career Highlights

Shu Len Liu is currently associated with Baxter International Inc., a leading company in the healthcare sector. His innovative work in developing fibrinogen complexes has positioned him as a key contributor to advancements in medical treatments